Loading…
Avience Biomedicals (AVIENCE)₹249.95−2.00%Medical Equipment & Supplies
At the end of the Jun 2026 quarter, Avience Biomedicals' shareholders were: promoters 64.56%, FIIs 3.04%, DIIs 9.07%, public 23.33%. 0.00% of promoter shares were pledged. It had 631 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2026 | |
|---|---|
| Promoters | 64.56% |
| FIIs | 3.04% |
| DIIs | 9.07% |
| Public | 23.33% |
| Promoter shares pledged | 0.00% |
| Number of shareholders | 631 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Dharam Deo Choudhary | Promoter | 37.23% | — |
| Ram Nagina Choudhary | Promoter | 11.77% | — |
| Deepa Choudhary | Promoter | 7.96% | — |
| Janardan Pal | Promoter | 7.67% | — |
| Maniramka Compound 365 Llp | Public | 3.68% | — |
| Sanshi Fund-I | DII | 2.63% | — |
| Meru Investment Fund Pcc-Cell 1 | FII | 2.22% | — |
| Fortune Hands Growth Fund- Fortune Hands Growth Fund Scheme | DII | 1.76% | — |
| Asnani Stock Broker Private Limited | Public | 1.49% | — |
| Huf | Public | 0.67% | — |
| NBFCs registered with RBI | DII | 0.09% | — |
| Arti Pal | Promoter | 0.02% | — |
| Geeta Choudhary | Promoter | 0.02% | — |
| Kapil Deo Choudhary | Promoter | 0.02% | — |
Promoters held 64.56% of Avience Biomedicals at the end of the Jun 2026 quarter.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 3.04% and domestic institutions (DIIs) held 9.07%.
No. The Jun 2026 filing shows no pledged promoter shares.
Avience Biomedicals had 631 shareholders at the end of the Jun 2026 quarter.
Maniramka Compound 365 Llp (Public) held 3.68% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.